FLUDARA

Šalis: Izraelis

kalba: anglų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

FLUDARABINE PHOSPHATE 50 MG/VIAL

Prieinama:

SANOFI - AVENTIS ISRAEL LTD

ATC kodas:

L01BB05

Vaisto forma:

POWDER FOR SOLUTION FOR INJ/INF

Vartojimo būdas:

I.V

Pagaminta:

GENZYME EUROPE B.V., NETHERLANDS

Farmakoterapinė grupė:

FLUDARABINE

Terapinės indikacijos:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

Leidimo data:

2009-02-01